Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.




There is no consensus on optimal treatment duration for propranolol in infantile hemangioma (IH). We evaluated the efficacy and safety of oral propranolol solution administered for a minimum of 6 months up to a maximum of 12 months of age in high-risk IH.
PMID: 30082451 [PubMed - as supplied by publisher]
PMID: 30082451 [PubMed - as supplied by publisher]